RBGPF - EU suggests label update to flag brain-related risks in certain cold drugs
2023-12-01 11:11:51 ET
More on Kenvue, Organon, etc.
- Organon: It's Darkest Before The Dawn
- Organon & Co (OGN) Piper Sandler 35th Annual Healthcare Conference (Transcript)
- Kenvue: Dude, Where's My Dividend Growth?
- Kenvue may be activist target amid recent 13-F filing
- FDA accepts supplemental application for Humira biosimilar from Samsung Bioepis, Organon
For further details see:
EU suggests label update to flag brain-related risks in certain cold drugs